RadioMedix -ViewPointMT collaboration featured on the cover of ACS Carbohydrate Newsletter

April 1st, 2014
read more

RadioMedix, Inc. Receives FDA Orphan Drug Designation for the 68Ga-DOTATATE (GalioMedix TM) for the management of the neuroendocrine tumors

January 2, 2014
read more

RadioMedix Inc. granted exclusive distribution authorization for ITG 68Ge/68Ga generators, and ITG iQS® Ga-68 Fluidic Labelling Module in U.S.A.


read more

RadioMedix’s scientists to present on the NANETS meeting

RadioMedix's scientists presented two posters on the NANETS meeting
read more

RadioMedix Scientists Presented on the 2013 SNMMI Annual Meeting in Vancouver, Canada


read more

RadioMedix signs collaborative agreement with Viewpoint Molecular Targeting, LLC of Iowa City IA


read more

cGMP Suite Registered by the FDA Drug Establishment Registration Database

January 11, 2013
read more

RadioMedix Inc. is a co-sponsor and collaborator on the two IND clinical trials

April 16, 2013
read more

RadioMedix Inc. Featured in the Small Chem Biz (SCHB) published by the American Chemical Society

RadioMedix Inc. Featured in the Small Chem Biz (SCHB) published by the American Chemical Society
read more

RadioMedix Receives $1.4 Million Second Tranche Investment from Texas Emerging Technology Fund


read more

Innovating Theranostics

RadioMedix, Inc. is a biotechnology company, based in Houston, Texas, focused on innovative targeted radiopharmaceuticals for diagnosis, monitoring and therapy of cancer. The company is commercializing generator-produced radiopharmaceuticals based on Gallium-68 chemistry. RadioMedix is in late-stage development of a new radiolabeled analog targeting metabolic pathway, GlucoMedix, which is based on its patented DO2A-chelation technology.

RadioMedix is introducing the SmartMedix™ automated laboratory system for synthesis of PET tracers for the research and clinical markets. RadioMedix has also established two service facilities for academic and industrial partners: cGMP Manufacturing Suite for clinical probe development and Molecular Imaging Facility for evaluation of agents in animal models.

Products & Services

RadioMedix offers unique products and services for Nuclear Medicine researchers and clinicians. Our products are SmartMedix System and GlucoMedix. We also provide services such as cGMP Drug Manufacturing Suite and Micro-PET Laboratory Services.

More >>

Investor Relations

Please contact Ebrahim Delpassand, MD for any additional information at edelpassand@radiomedix.com

More >>